VISION-DMD

Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy

Search

  • The Project
    • Summary
    • Project Objectives
    • Project Consortium
    • Contact us
  • About DMD
    • What is DMD?
    • Living with Duchenne
    • Current treatment options
    • Duchenne boy’s stories
    • DMD Community
    • Standards of Care for Duchenne muscular dystrophy
  • Study Information
    • What is a clinical study?
    • Phase 2a clinical trial information
    • Phase 2a preliminary study results
    • Phase 2b clinical trial information
    • MRI – Magnetic Resonance Imaging
    • Biomarkers
    • Vamorolone study APP for boys
  • Drug Development
    • Development of Vamorolone
    • Vamorolone development programme
  • Funding Model
    • Patient Group Funders
    • What is Venture Philanthropy?
  • Resources
    • Relevant publications
      • VISION-DMD INFORMATION APP OVERVIEW
    • VISION-DMD Workshops
      • Workshop series: Standards of Care
      • Workshop series: Biomarkers and Imaging
    • Webinars and presentations
    • Press Releases
    • VISION-DMD project Interviews
      • An Interview with Andrea Smith – Clinical research project manager at TRiNDS
      • Interview with Jana Haberlová – Paediatric Neurologist at University Hospital Motol
      • Interview with Alex Johnson: a parent and patient foundation funder
    • VISION-DMD Project Newsletters
      • VISION-DMD newsletter sign up
    • VISION-DMD Poster presentations
    • Our privacy policy
  • enEnglish
    • nlNederlands
    • frFrançais
    • deDeutsch
    • itItaliano
    • esEspañol

Webinars and presentations

Vamorolone Clinical Trials in Duchenne, hosted by Parent Project Muscular Dystrophy

Wednesday 30th January 2019.  7pm Central European Time (6pm GMT)

Click here to register

Past webinars

WDO webinar on -a patients perspective -November 2018

WDO webinar Update on vamorolone – September 2018

Read the webinar lay report here

PPMD conference presentation of preliminary Phase 2a results – June 2018

 

 

 

 

 

 

 

 

PPMD webinar vamorolone clinical trials in Duchenne – January 2017

Follow us on twitter

  • Twitter

EUFlag2020

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 667078.

To find out more about the project contact us at vision-dmd_team@ceratium.eu

VISION-DMD Copyright © 2019 · Log in

Multilingual WordPress with WPML

Cookies

This site uses cookies: Find out more.